Company intelligence / Profile preview

GPB Capital Holdings

New York City, New York, United States

Ownership: Private
Employees: ~5
Development stage: Other

Overview

GPB Capital Holdings was an asset management firm that raised over $1.7 billion to invest in middle-market businesses across various sectors, including some exposure to life sciences and healthcare through portfolio companies. The firm has been embroiled in legal and regulatory controversy, accused by the SEC of operating a Ponzi-like scheme. The company suspended operations and investor redemptions in 2018; as of 2022, its business is essentially defunct with assets in receivership.

Industry: Investors

Partnerships

Emmaus Life SciencesITelagen

Beyond the preview

Go deeper on GPB Capital Holdings.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on GPB Capital Holdings.

Explore the full profile